Clinical Trial Update: Paired Psoriasis Lesion, Comparative, Study to Evaluate MOL4239 in Psoriasis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating MOL4239 in psoriasis completed, with results posted in December 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• MOL4239

Snippet

Sponsor: Moleculin, LLC | Conditions: Psoriasis | Phase 2 | Status: COMPLETED | Results posted: 2014-12-24